Tweetable abstract for social media:
This study aimed to determine the efficacy of nephrin as a biomarker in
maternal urine to predict preeclampsia (PE). Patients who had been
diagnosed with PE were included and patients without a history of
underlying diseases were recruited for the control group. Urine samples
were obtained, and nephrin signaling was detected. Nephrin signals were
classified into four groups. In the PE group, signals 0, 1, 2, and 3
were found in 18.4%, 44.9%, 24.5%, and 12.2% of participants. In the
control group, in which 84.3% were found to have signal 0
(P <0.001). The severity of PE was, however, implied
according to the intensity of signals in this study.